Associate Professor at the Universidad Complutense de Madrid
Head of the Lung Cancer Unit at the CNIO (Spanish National Cancer Research Center), Madrid
President of ASEICA (Spanish Association of Cancer Research)
The latest Diaceutics virtual event, “Precision medicine in oncology”, will allow you to join the forefront of cancer testing and treatment, with a series of 8 live webinars, culminating in a full day true-to-life virtual event. During these events, you’ll get exclusive access to clinical insights from top European lab experts.
This series of webinars will cover cutting-edge topics including immunotherapy, liquid biopsy, pre-analytical phase, NGS, cytology, and CE-IVDR. These topics are revolutionizing cancer analysis and diagnostics. During this series of events, you can learn about the latest technologies and tools being used in this field.
Attendees can participate in interactive sessions and engage in real-time Q&A sessions with the expert speakers, providing a chance to ask questions and gain a deeper insight and understanding of these increasingly relevant topics.
Join us for our events that are designed specifically for laboratory professionals, pathologists, and anyone involved in oncology diagnostics and treatment. Stay up to date with the latest developments in precision medicine and be part of shaping the future of cancer treatment. Don’t miss out on this exciting opportunity to connect with experts in the field and take your knowledge to the next level.
In this first event of the “Precision medicine in oncology” series, Dr Taniere (Pathologist, University Hospitals Birmingham, UK) and Dr Paz-Ares (Medical Oncologist, Hospital Universitario 12 de Octubre, Madrid Spain) will share insights on the state of the art both in terms of biomarker testing, and clinical utility of the use of immunotherapy as a multi-disease treatment option. They will explore across different oncological diseases, the importance of biomarkers such as PD-L1, MMR/MSI and TMB for immunotherapy response and explain what patient criteria mandate biomarker testing in advance of prescribing.
Join us for this event that is designed specifically for laboratory professionals, pathologists, and anyone involved in oncology diagnostics and treatment. Attendees can participate in interactive sessions and engage in real-time Q&A sessions with the expert speakers, providing a chance to ask questions and gain a deeper insight and understanding of these increasingly relevant topics.
Sign up today so not to miss out.
DXRX is a digital gateway that answers the needs of all precision medicine stakeholders, integrating multiple pipelines of real-world diagnostic testing data from a global network of labs.
DXRX places labs at the center of the network, unlocking collaboration opportunities with other labs and world-leading pharma. We aim to connect labs, pharma and diagnostic companies at a local, national, and global level.
DXRX has been purpose built to address challenges in testing that labs face every day and offers collaboration opportunities designed to solve each barrier.
By signing up to DXRX, you have the opportunity to: